Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
Sinovac Biotech Total Assets (Quarterly): 12.90B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 12.90B |
| June 30, 2024 | 12.90B |
| December 31, 2023 | 13.66B |
| June 30, 2023 | 13.73B |
| June 30, 2023 | 13.73B |
| December 31, 2022 | 14.11B |
| June 30, 2022 | 15.07B |
| December 31, 2021 | 16.75B |
| June 30, 2021 | 12.63B |
| December 31, 2020 | 1.901B |
| September 30, 2020 | 658.56M |
| June 30, 2020 | 529.37M |
| March 31, 2020 | 433.32M |
| December 31, 2019 | 452.30M |
| September 30, 2019 | 410.65M |
| June 30, 2019 | 403.83M |
| March 31, 2019 | 381.85M |
| December 31, 2018 | 369.78M |
| June 30, 2018 | 307.67M |
| December 31, 2017 | 299.22M |
| June 30, 2017 | 245.42M |
| December 31, 2016 | 211.36M |
| September 30, 2016 | 203.72M |
| June 30, 2016 | 181.42M |
| March 31, 2016 | 204.51M |
| Date | Value |
|---|---|
| December 31, 2015 | 202.93M |
| September 30, 2015 | 204.33M |
| June 30, 2015 | 217.71M |
| March 31, 2015 | 212.46M |
| December 31, 2014 | 238.53M |
| September 30, 2014 | 242.34M |
| June 30, 2014 | 230.60M |
| March 31, 2014 | 238.43M |
| December 31, 2013 | 240.69M |
| September 30, 2013 | 225.60M |
| June 30, 2013 | 222.63M |
| March 31, 2013 | 215.78M |
| December 31, 2012 | 208.76M |
| September 30, 2012 | 209.96M |
| June 30, 2012 | 210.97M |
| March 31, 2012 | 209.41M |
| December 31, 2011 | 215.91M |
| September 30, 2011 | 207.28M |
| June 30, 2011 | 202.12M |
| March 31, 2011 | 203.37M |
| December 31, 2010 | 214.36M |
| September 30, 2010 | 218.59M |
| June 30, 2010 | 207.87M |
| March 31, 2010 | 224.91M |
| December 31, 2009 | 145.48M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
433.32M
Minimum
Mar 2020
16.75B
Maximum
Dec 2021
9.245B
Average
12.90B
Median
Jun 2024
Total Assets (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | 63.62M |
| Zai Lab Ltd | 985.35M |
| China SXT Pharmaceuticals Inc | 23.13M |
| Adagene Inc | 100.78M |
| LakeShore Biopharma Co Ltd | 220.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.390B |
| Shareholders Equity (Quarterly) | 8.649B |
| Debt to Equity Ratio | 0.0358 |
| Current Ratio | 11.39 |
| Net Debt Paydown Yield | -21.04% |